The therapeutic landscape for PsA continues to expand. Patients and prescribers now have a wide range of options for disease management. Traditional DMARDs, biologics, and targeted synthetic DMARDs have revolutionised the treatment of PsA, providing improved patient outcomes and quality of life.

Lilly invites you to join international dermatology experts Dr Laura Savage and A/Prof Peter Foley, KOL for an interactive discussion on PsO to PsA.

This institute update will be presented by Dr Josie Yeatman, dermatologist who runs the Liaison clinic in collaboration with psychiatrist Dr Melissa Thomas.

The PBA Advisory Committee has introduced a risk share (cap) arrangement that may affect the accessibility of new therapies for Atopic Dermatitis. Join us to learn more about RSAs and what clinicians can do to improve their patient's quality of life.

Join us for an engaging conversation with Professor John Kelly and Associate Professor Robert Kelly as they generously recount their professional odysseys, offering insights into their experiences as dermatologists.

Join Dr Andrew Pink and A/Prof Peter Foley as they explore the treat-to-target strategy and algorithm, a dynamic framework adjusting to evolving therapies. Discover refinements in chronic skin condition management.

Join us for a captivating session in our Legacy Series as we delve into the distinguished professional journey of Dr Michael Rich, a renowned specialist in dermatology.

The Skin Health Institute is proud to partner with Bristol Myers Squibb and the Australasian Dermatology Registry to bring you an exclusive roadshow event.

The Skin Health Institute is proud to partner with Bristol Myers Squibb and the Australasian Dermatology Registry to bring you an exclusive roadshow event in Sydney.

The Skin Health Institute is proud to partner with Bristol Myers Squibb and the Australasian Dermatology Registry to bring you an exclusive roadshow event in Brisbane.